Delivery Order SPE2DX22D0030-SPE2D826F0BA3

This delivery order, awarded on October 28, 2025, represents a $7,702.73 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-competitive, reflecting the established relationship under the prime indefinite delivery vehicle that serves as a comprehensive pharmaceutical support mechanism for military healthcare programs. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Through its DLA Troop Support Medical contract, the company provides brand-name and generic medications, vaccines, specialty pharmaceuticals, medical devices, and related healthcare commodities across multiple therapeutic domains to authorized federal customers including the Defense Health Agency and U.S. Coast Guard. The company's competitive position is evidenced by its selection as a potential contractor for the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative, which anticipates multiple awards across separate geographic regions.